Prostaglandins E2 and E1 inhibit cytokine-induced metalloprotease expression in human synovial fibroblasts. Mediation by cyclic-AMP signalling pathway
- PMID: 8078306
Prostaglandins E2 and E1 inhibit cytokine-induced metalloprotease expression in human synovial fibroblasts. Mediation by cyclic-AMP signalling pathway
Abstract
Background: Cytokine modulated matrix metalloprotease (MMP, i.e., collagenase and stromelysin) synthesis may be associated etiologically with osteoarthritic diseases. The aim of this study was to investigate the mode of action by which interleukin-1 beta (IL-1 beta) induced collagenase and stromelysin mRNA expression and synthesis in normal human synoviocytes and to explore mechanisms of suppression of these proteolytic enzymes by prostaglandins (PG).
Experimental design: Collagenase and stromelysin expression and synthesis were induced in cultured human synoviocytes with rhIL-1 beta in the absence or presence of either chemical inhibitors of protein kinase (PK) A and C, PGE2 or PGE1, or cAMP mimetics. We used enzyme immunoassays to determine MMP antigen levels in spent culture medium and Northern hybridization to measure steady-state MMP mRNA expression.
Results: Dose-response experiments revealed that 10 pg/ml of interleukin-1 beta was an effective sub-saturating concentration for the induction of collagenase and stromelysin expression in normal human synovial fibroblasts. The rate of collagenase synthesis and expression peaked at 18 to 24 hours after rhIL-1 beta stimulation, whereas stromelysin output increased steadily within the experimental time frame (72 hours). Protein kinase C inhibitors, H-7 and staurosporine, prevented the rhIL-1 beta induction of MMP mRNA expression and protein synthesis. Pretreatment of synoviocytes with phorbol myristate acetate for 18 hours abrogated the ability of rhIL-1 beta to induce MMP synthesis. Prostaglandins E2 and E1 potently inhibited in a dose-dependent fashion rhIL-1 beta induced MMP synthesis: PGE2, IC50, collagenase, 2.3 ng/ml; stromelysin, 21.2 ng/ml; PGE1, IC50, collagenase, 2.5 ng/ml; stromelysin, 13.4 ng/ml. MMP mRNA steady-state levels were suppressed in a fashion similar to that of the protein synthesis. Forskolin, dibutyryl cAMP, and 3-isobutyl-1-methyl xanthine mimicked the effects of the prostaglandins (PGs). [N-(2-methyl-amino)-5-isoquinoline-sulfonamide dihydrochloride] (H-8), an inhibitor of PKA activity, could reverse to a large extent, the suppressive effects of the PGs as did cycloheximide when preincubated with PGE2 before rhIL-1 beta activation of synoviocytes.
Conclusions: We conclude that IL-1 beta stimulates MMP synthesis by activating PKC but not PKA, and that the synthesis of collagenase and stromelysin is discoordinate on a temporal and quantitative basis. PGs inhibit rhIL-1 beta-induced MMP expression and synthesis by virtue of their ability to increase cAMP intracellular levels and subsequent activation of signal transduction mechanisms involving PKA. Homeostasis may be maintained in acute episodes of joint inflammation through feedback processes involving locally produced eicosanoids.
Similar articles
-
Coordinate regulation of matrix metalloproteases and tissue inhibitor of metalloproteinase expression in human synovial fibroblasts.J Rheumatol Suppl. 1995 Feb;43:123-8. J Rheumatol Suppl. 1995. PMID: 7752115
-
Interleukin-1 beta induction of tissue inhibitor of metalloproteinase (TIMP-1) is functionally antagonized by prostaglandin E2 in human synovial fibroblasts.J Cell Biochem. 1995 Apr;57(4):619-29. doi: 10.1002/jcb.240570406. J Cell Biochem. 1995. PMID: 7615646
-
Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines.Arthritis Rheum. 1998 Oct;41(10):1748-59. doi: 10.1002/1529-0131(199810)41:10<1748::AID-ART7>3.0.CO;2-3. Arthritis Rheum. 1998. PMID: 9778216
-
Role of matrix metalloproteinases and their inhibition in cutaneous wound healing and allergic contact hypersensitivity.Ann N Y Acad Sci. 1999 Jun 30;878:12-24. doi: 10.1111/j.1749-6632.1999.tb07671.x. Ann N Y Acad Sci. 1999. PMID: 10415717 Review.
-
Prostaglandins and their regulation in rheumatoid inflammation.Ann N Y Acad Sci. 1979;332:279-94. doi: 10.1111/j.1749-6632.1979.tb47122.x. Ann N Y Acad Sci. 1979. PMID: 231404 Review.
Cited by
-
COX-2, NO, and cartilage damage and repair.Curr Rheumatol Rep. 2000 Dec;2(6):447-53. doi: 10.1007/s11926-000-0019-5. Curr Rheumatol Rep. 2000. PMID: 11123096 Review.
-
Prostaglandin PGE2 at very low concentrations suppresses collagen cleavage in cultured human osteoarthritic articular cartilage: this involves a decrease in expression of proinflammatory genes, collagenases and COL10A1, a gene linked to chondrocyte hypertrophy.Arthritis Res Ther. 2007;9(4):R75. doi: 10.1186/ar2273. Arthritis Res Ther. 2007. PMID: 17683641 Free PMC article.
-
Suppression of matrix metalloproteinase production in nasal fibroblasts by tranilast, an antiallergic agent, in vitro.Mediators Inflamm. 2005 Aug 14;2005(3):150-9. doi: 10.1155/MI.2005.150. Mediators Inflamm. 2005. PMID: 16106101 Free PMC article.
-
Prostaglandin E2 differentially modulates proinflammatory/prodestructive effects of TNF-alpha on synovial fibroblasts via specific E prostanoid receptors/cAMP.J Immunol. 2009 Jul 15;183(2):1328-36. doi: 10.4049/jimmunol.0900801. Epub 2009 Jun 19. J Immunol. 2009. PMID: 19542367 Free PMC article.
-
Interleukin-4 inhibition of interleukin-1-induced expression of matrix metalloproteinase-3 (MMP-3) is independent of lipoxygenase and PPARgamma activation in human gingival fibroblasts.BMC Mol Biol. 2007 Feb 23;8:12. doi: 10.1186/1471-2199-8-12. BMC Mol Biol. 2007. PMID: 17319946 Free PMC article.